Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Bruce Wilkoff, MD, is the Director of Cardiac Pacing and Tachyarrhythmia Devices; Associate Section Head of the Pacing and Electrophysiology Section; Medical Information Officer of the Heart & Vascular Institute; and a staff cardiologist in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Section of Cardiac Pacemakers and Electrophysiology at Cleveland Clinic. He is Professor of Medicine at Cleveland Clinic Lerner College of Medicine at Case Western Reserve University. Dr. Wilkoff is board-certified in internal medicine and cardiovascular disease, and since 1988, he has served on the examination writing committee for Special Competency in Cardiac Pacing and Defibrillation.
Specialty/Clinical interests: Abnormal Heart Rhythms, bradyarrhythmias, sudden cardiac death, supraventricular tachycardia, ventricular tachycardia, biventricular pacemaker, lead extraction, implantable cardioverter defibrillator, pacemaker implant, cardiac implantable electronic device infection
Number of Procedures Performed: Dr. Wilkoff has performed more than 10,000 pacemaker and defibrillator procedures and more than 3,000 transvenous lead extractions throughout his career.
Success Rates: Cleveland Clinic has been ranked the #1 hospital for cardiology and heart surgery by U.S. News & World Report since 1994. Success rates for specific procedures are available at http://my.clevelandclinic.org/heart/about-heart-vascular-institute/treatment-outcomes.aspx
Education and Training: Dr. Wilkoff earned a Bachelor of Science degree in biomedical engineering at Northwestern University. He received his medical degree from the Ohio State University College of Medicine in Columbus. He completed his clinical training in internal medicine at Case Western Reserve University and University Hospitals of Cleveland, followed by a fellowship in cardiology from University Hospitals and a fellowship in research from the Ohio State University Hospital and School of Veterinary Medicine. Dr. Wilkoff was appointed to Cleveland Clinic in 1986 as a clinical associate, in 1987 as full staff in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, and in 2005 as Professor of Medicine in the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
Dr. Wilkoff is recognized as an international expert in the design of new technologies to improve the performance of pacemakers and defibrillators. He is involved in numerous multi-center clinical trials to study medical applications for pacemakers and defibrillators. Dr. Wilkoff holds eight U.S. patents, including a special algorithm for defibrillator tachycardia detection and an efficient controller for pacemaker rate responsiveness.
Publications and Speaking: Dr. Wilkoff has authored or co-authored more than 300 articles published in scientific journals. He serves as a reviewer for many leading professional journals including American Heart Journal, American Journal of Cardiology, and Circulation, and he serves on the editorial board for Journal of Cardiovascular Electrophysiology, Heart Rhythm, and Journal of Interventional Cardiac Electrophysiology. He is associate editor of Pacing and Clinical Electrophysiology.
Dr. Wilkoff is co-editor of "Clinical Cardiac Pacing, Defibrillation and Resynchronization Therapy", which is the most comprehensive and authoritative text in the field of implantable cardiac rhythm devices. The fourth edition of this book was published in 2011. From 2004 to 2007, Dr. Wilkoff co-authored the annual "Coding Guide for Heart Rhythm Procedures and Services" for the Heart Rhythm Society.$0$0Dr. Wilkoff is a Fellow of the American College of Cardiology, Heart Rhythm Society and the American Heart Association. He has held leadership positions on committees and councils in each of these organizations and recently served as the President and member of the Board of Trustees and Executive Committees of the Heart Rhythm Society.
About Dr. Wilkoff: “I want patients to be confident that when they come to the Cleveland Clinic their problems can be solved.”
Leisure Activities: Using his computer, listening to music, ballroom dancing, and spending time with his wife, children and 4 grandchildren.
Abnormal Heart Rhythms, bradyarrhythmias, sudden cardiac death, supraventricular tachycardia, ventricular tachycardia, biventricular pacemaker, lead extraction, implantable cardioverter defibrillator, pacemaker implant, cardiac implantable electronic device infection Abnormal Heart Rhythms, Bradyarrhythmias, Sudden Cardiac Death, Supraventricular Tachycardia, Ventricular Tachycardia, Biventricular Pacemaker, Lead Extraction, Implantable Cardioverter Defibrillator, Pacemaker Implant, Cardiac Implantable Electronic Device Infection
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 5/4/2015, Dr. Wilkoff has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Consulting and/or Speaking. Dr. Wilkoff receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:
- Medtronic, Inc.
- Spectranetics Corp
Royalty Payments. Dr. Wilkoff receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.